Histogen Inc (HSTO)
0.1001
-0.40
(-79.98%)
USD |
OTCM |
Apr 19, 11:58
Histogen Cash from Investing (TTM): 0.012M for Sept. 30, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
September 30, 2023 | 0.012M |
June 30, 2023 | -0.009M |
March 31, 2023 | -0.20M |
December 31, 2022 | -0.216M |
September 30, 2022 | -0.365M |
June 30, 2022 | -0.402M |
Date | Value |
---|---|
March 31, 2022 | -0.256M |
December 31, 2021 | -0.241M |
September 30, 2021 | -0.097M |
June 30, 2021 | -1.381M |
March 31, 2021 | 11.37M |
December 31, 2020 | 10.97M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-1.381M
Minimum
Jun 2021
11.37M
Maximum
Mar 2021
1.599M
Average
-0.208M
Median
Cash from Investing (TTM) Benchmarks
CEL-SCI Corp | -0.3835M |
AIM ImmunoTech Inc | -0.832M |
IGC Pharma Inc | -0.236M |
NovaBay Pharmaceuticals Inc | -0.019M |
Protalix BioTherapeutics Inc | -16.71M |